205 related articles for article (PubMed ID: 19853305)
1. Influence of divalent copper, manganese and zinc ions on fibril nucleation and elongation of the amyloid-like yeast prion determinant Sup35p-NM.
Suhre MH; Hess S; Golser AV; Scheibel T
J Inorg Biochem; 2009 Dec; 103(12):1711-20. PubMed ID: 19853305
[TBL] [Abstract][Full Text] [Related]
2. Copper(II) inhibits in vitro conversion of prion protein into amyloid fibrils.
Bocharova OV; Breydo L; Salnikov VV; Baskakov IV
Biochemistry; 2005 May; 44(18):6776-87. PubMed ID: 15865423
[TBL] [Abstract][Full Text] [Related]
3. Prion protein/protein interactions: fusion with yeast Sup35p-NM modulates cytosolic PrP aggregation in mammalian cells.
Krammer C; Suhre MH; Kremmer E; Diemer C; Hess S; Schätzl HM; Scheibel T; Vorberg I
FASEB J; 2008 Mar; 22(3):762-73. PubMed ID: 17928365
[TBL] [Abstract][Full Text] [Related]
4. The formation of Escherichia coli curli amyloid fibrils is mediated by prion-like peptide repeats.
Cherny I; Rockah L; Levy-Nissenbaum O; Gophna U; Ron EZ; Gazit E
J Mol Biol; 2005 Sep; 352(2):245-52. PubMed ID: 16083908
[TBL] [Abstract][Full Text] [Related]
5. The role of conformational flexibility in prion propagation and maintenance for Sup35p.
Scheibel T; Lindquist SL
Nat Struct Biol; 2001 Nov; 8(11):958-62. PubMed ID: 11685242
[TBL] [Abstract][Full Text] [Related]
6. Effects of randomizing the Sup35NM prion domain sequence on formation of amyloid fibrils in vitro.
Liu Y; Wei H; Wang J; Qu J; Zhao W; Tao H
Biochem Biophys Res Commun; 2007 Feb; 353(1):139-46. PubMed ID: 17166483
[TBL] [Abstract][Full Text] [Related]
7. Oligopeptide repeats in the yeast protein Sup35p stabilize intermolecular prion interactions.
Parham SN; Resende CG; Tuite MF
EMBO J; 2001 May; 20(9):2111-9. PubMed ID: 11331577
[TBL] [Abstract][Full Text] [Related]
8. Protein-only transmission of three yeast prion strains.
King CY; Diaz-Avalos R
Nature; 2004 Mar; 428(6980):319-23. PubMed ID: 15029195
[TBL] [Abstract][Full Text] [Related]
9. Interaction of the human prion PrP(106-126) sequence with copper(II), manganese(II), and zinc(II): NMR and EPR studies.
Gaggelli E; Bernardi F; Molteni E; Pogni R; Valensin D; Valensin G; Remelli M; Luczkowski M; Kozlowski H
J Am Chem Soc; 2005 Jan; 127(3):996-1006. PubMed ID: 15656638
[TBL] [Abstract][Full Text] [Related]
10. The physical basis of how prion conformations determine strain phenotypes.
Tanaka M; Collins SR; Toyama BH; Weissman JS
Nature; 2006 Aug; 442(7102):585-9. PubMed ID: 16810177
[TBL] [Abstract][Full Text] [Related]
11. Generation of prion transmission barriers by mutational control of amyloid conformations.
Chien P; DePace AH; Collins SR; Weissman JS
Nature; 2003 Aug; 424(6951):948-51. PubMed ID: 12931190
[TBL] [Abstract][Full Text] [Related]
12. Raman optical activity and circular dichroism reveal dramatic differences in the influence of divalent copper and manganese ions on prion protein folding.
Zhu F; Davies P; Thompsett AR; Kelly SM; Tranter GE; Hecht L; Isaacs NW; Brown DR; Barron LD
Biochemistry; 2008 Feb; 47(8):2510-7. PubMed ID: 18205409
[TBL] [Abstract][Full Text] [Related]
13. [New aspects of research upon the yeast Saccharomyces cerevisiae [PSI+] prion].
Ishikawa T
Postepy Biochem; 2007; 53(2):182-7. PubMed ID: 17969880
[TBL] [Abstract][Full Text] [Related]
14. [Structure and functional similarity of yeast Sup35p and Ure2p proteins to mammalian prions].
Kushnirov VV; Ter-Avanesian MD; Smirnov VN
Mol Biol (Mosk); 1995; 29(4):750-5. PubMed ID: 7476941
[TBL] [Abstract][Full Text] [Related]
15. [Chimeric yeast prions with unstable inheritance].
Borkhsenius AS; Sasnauskas K; Gedvilaĭte A; Inge-Vechtomov SG
Genetika; 2002 Mar; 38(3):300-5. PubMed ID: 11963556
[TBL] [Abstract][Full Text] [Related]
16. Amyloid of the prion domain of Sup35p has an in-register parallel beta-sheet structure.
Shewmaker F; Wickner RB; Tycko R
Proc Natl Acad Sci U S A; 2006 Dec; 103(52):19754-9. PubMed ID: 17170131
[TBL] [Abstract][Full Text] [Related]
17. An efficient protein transformation protocol for introducing prions into yeast.
Tanaka M; Weissman JS
Methods Enzymol; 2006; 412():185-200. PubMed ID: 17046659
[TBL] [Abstract][Full Text] [Related]
18. Covalent blocking of fibril formation and aggregation of intracellular amyloidgenic proteins by transglutaminase-catalyzed intramolecular cross-linking.
Konno T; Morii T; Hirata A; Sato S; Oiki S; Ikura K
Biochemistry; 2005 Feb; 44(6):2072-9. PubMed ID: 15697232
[TBL] [Abstract][Full Text] [Related]
19. Prion properties of the Sup35 protein of yeast Pichia methanolica.
Kushnirov VV; Kochneva-Pervukhova NV; Chechenova MB; Frolova NS; Ter-Avanesyan MD
EMBO J; 2000 Feb; 19(3):324-31. PubMed ID: 10654931
[TBL] [Abstract][Full Text] [Related]
20. Aggregation/fibrillogenesis of recombinant human prion protein and Gerstmann-Sträussler-Scheinker disease peptides in the presence of metal ions.
Ricchelli F; Buggio R; Drago D; Salmona M; Forloni G; Negro A; Tognon G; Zatta P
Biochemistry; 2006 May; 45(21):6724-32. PubMed ID: 16716083
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
